American Trust Novo Cure LTD Transaction History

American Trust

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Dec 02, 2022	BUY	$67.99 - $89.57 $185,680 - $244,615	2,731 New	2,731 $208,000
Q2 2022 Oct 03, 2022	SELL	$56.6 - $89.9 $158,706 - $252,079	-2,804 Closed	0 $0
Q1 2022 Jun 08, 2022	SELL	$60.15 - $84.52 $9,924 - $13,945	-165 Reduced 5.56%	2,804 $232,000
Q4 2021 Mar 17, 2022	BUY	$75.08 - $121.99 $222,912 - $362,188	2,969 New	2,969 $223,000

264

76.5M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $2.49B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of American Trust, based on Form 13F filings with the SEC.

Stay updated on American Trust with notifications on news.